Broadview Advisors Decreased Schlumberger LTD (SLB) Holding By $317,400; Anika Therapeutics Has 1.42 Sentiment

January 13, 2018 - By Winifred Garcia

Broadview Advisors Llc decreased Schlumberger Ltd (SLB) stake by 52.87% reported in 2017Q3 SEC filing. Broadview Advisors Llc sold 4,600 shares as Schlumberger Ltd (SLB)’s stock declined 11.04%. The Broadview Advisors Llc holds 4,100 shares with $286,000 value, down from 8,700 last quarter. Schlumberger Ltd now has $108.01 billion valuation. The stock increased 1.19% or $0.92 during the last trading session, reaching $77.97. About 9.21 million shares traded or 1.33% up from the average. Schlumberger Limited (NYSE:SLB) has declined 3.30% since January 13, 2017 and is downtrending. It has underperformed by 20.00% the S&P500.

Anika Therapeutics, Inc., together with its subsidiaries, provides orthopedic medicines for patients with degenerative orthopedic diseases and traumatic conditions in the United States and internationally. The company has market cap of $830.44 million. The firm develops, makes, and commercializes therapeutic products based on its proprietary hyaluronic acid technology. It has a 26.72 P/E ratio. The Company’s orthobiologics products comprise ORTHOVISC, ORTHOVISC mini, MONOVISC, and CINGAL for the treatment of osteoarthritis of the knee; HYALOFAST, a biodegradable support for human bone marrow mesenchymal stem cells used for cartilage regeneration and as an adjunct for microfracture surgery; HYALONECT, a woven gauze used as a bone graft wrap; HYALOSS used to mix blood/bone grafts to form a paste for bone regeneration; and HYALOGLIDE, an ACP gel used in tenolysis treatment.

Broadview Advisors Llc increased Brunswick Corp (NYSE:BC) stake by 47,825 shares to 180,735 valued at $10.12 million in 2017Q3. It also upped Bmc Stk Hldgs Inc stake by 31,167 shares and now owns 592,336 shares. K2m Group Hldgs Inc (NASDAQ:KTWO) was raised too.

Investors sentiment is 0.88 in Q3 2017. Its the same as in 2017Q2. It has no change, as 69 investors sold SLB shares while 596 reduced holdings. only 105 funds opened positions while 481 raised stakes. 1.20 billion shares or 11.55% more from 1.07 billion shares in 2017Q2 were reported. Keybank National Association Oh holds 625,882 shares. Kayne Anderson Rudnick Management Lc reported 0% in Schlumberger Limited (NYSE:SLB). Synovus Fincl accumulated 56,301 shares. Louisiana State Employees Retirement holds 0.28% or 86,800 shares in its portfolio. Deltec Asset Mgmt Llc holds 1.76% or 124,842 shares in its portfolio. Capital Interest stated it has 10.03 million shares or 0.84% of all its holdings. Hyman Charles D reported 22,825 shares. Cadinha & Limited Com holds 4,200 shares. First Advsr LP accumulated 296,787 shares. Manning & Napier Advsrs Ltd Liability Corp accumulated 4.81 million shares or 2.88% of the stock. The Connecticut-based Benin Mngmt has invested 4.19% in Schlumberger Limited (NYSE:SLB). Mutual Of Omaha State Bank Wealth Management has 3,150 shares for 0.08% of their portfolio. Vident Investment Advisory Ltd Liability Corporation holds 15,339 shares. Bridges Investment Counsel owns 13,090 shares or 0.51% of their US portfolio. Whittier Company Of Nevada, Nevada-based fund reported 30,519 shares.

Among 35 analysts covering Schlumberger Limited. (NYSE:SLB), 27 have Buy rating, 1 Sell and 7 Hold. Therefore 77% are positive. Schlumberger Limited. had 127 analyst reports since July 22, 2015 according to SRatingsIntel. Barclays Capital maintained Schlumberger Limited (NYSE:SLB) rating on Wednesday, October 25. Barclays Capital has “Equal-Weight” rating and $70 target. As per Friday, August 25, the company rating was maintained by Jefferies. The firm has “Buy” rating given on Saturday, August 22 by Evercore. HSBC maintained the shares of SLB in report on Thursday, September 3 with “Buy” rating. The stock of Schlumberger Limited (NYSE:SLB) earned “Equal-Weight” rating by Barclays Capital on Wednesday, June 21. The stock of Schlumberger Limited (NYSE:SLB) has “Buy” rating given on Tuesday, November 15 by Jefferies. SunTrust upgraded it to “Buy” rating and $92 target in Friday, April 21 report. Citigroup maintained the shares of SLB in report on Wednesday, March 23 with “Buy” rating. On Monday, May 23 the stock rating was upgraded by Goldman Sachs to “Conviction Buy”. The firm earned “Buy” rating on Friday, February 19 by DA Davidson.

Since October 24, 2017, it had 0 insider purchases, and 1 sale for $219,205 activity. SANDVOLD TORE I sold 3,500 shares worth $219,205.

Analysts await Schlumberger Limited (NYSE:SLB) to report earnings on January, 19. They expect $0.45 EPS, up 66.67% or $0.18 from last year’s $0.27 per share. SLB’s profit will be $623.37 million for 43.32 P/E if the $0.45 EPS becomes a reality. After $0.42 actual EPS reported by Schlumberger Limited for the previous quarter, Wall Street now forecasts 7.14% EPS growth.

Analysts await Anika Therapeutics, Inc. (NASDAQ:ANIK) to report earnings on February, 21. They expect $0.54 earnings per share, 0.00% or $0.00 from last year’s $0.54 per share. ANIK’s profit will be $7.92M for 26.22 P/E if the $0.54 EPS becomes a reality. After $0.46 actual earnings per share reported by Anika Therapeutics, Inc. for the previous quarter, Wall Street now forecasts 17.39% EPS growth.

The stock increased 0.82% or $0.46 during the last trading session, reaching $56.64. About 53,185 shares traded. Anika Therapeutics, Inc. (ANIK) has risen 4.53% since January 13, 2017 and is uptrending. It has underperformed by 12.17% the S&P500.